The role of ZEB1 in the modulation of NSC function, particularly under neuroinflammatory conditions, makes it an attractive target for NSC-based therapies in various neurological disorders, such as multiple sclerosis, traumatic brain injury, and neurodegenerative diseases. Here, ZEB1 is linked to neurodegenerative disease.